Clinical Trial Update: Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects. [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics data for oral EPX-100 in healthy subjects. The study supports continued development for Dravet Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• EPX-100 (Clemizole hydrochloride)

Snippet

Sponsor: Epygenix | Conditions: Dravet Syndrome | Phase 1 | Status: COMPLETED